Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 12 Nov 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 12 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2005 New trial record.